Croda International (LON:CRDA) Insider Acquires £164.60 in Stock

Croda International Plc (LON:CRDAGet Free Report) insider Stephen Oxley acquired 5 shares of the firm’s stock in a transaction on Monday, August 10th. The stock was purchased at an average cost of GBX 3,292 per share, with a total value of £164.60.

Stephen Oxley also recently made the following trade(s):

  • On Monday, August 3rd, Stephen Oxley sold 1,339 shares of Croda International stock. The shares were sold at an average price of GBX 3,214, for a total value of £43,035.46.
  • On Friday, July 10th, Stephen Oxley purchased 5 shares of Croda International stock. The stock was bought at an average price of GBX 2,859 per share, for a total transaction of £142.95.
  • On Wednesday, June 10th, Stephen Oxley acquired 5 shares of Croda International stock. The stock was purchased at an average cost of GBX 2,965 per share, for a total transaction of £148.25.

Croda International Stock Performance

Shares of Croda International stock opened at GBX 3,274 on Tuesday. The company has a current ratio of 2.57, a quick ratio of 2.25 and a debt-to-equity ratio of 36.06. Croda International Plc has a 12 month low of GBX 2,426.77 and a 12 month high of GBX 3,352. The stock’s fifty day moving average price is GBX 3,041.96 and its 200-day moving average price is GBX 2,935.61. The firm has a market cap of £4.56 billion, a P/E ratio of 57.54, a P/E/G ratio of 1.40 and a beta of 0.92.

Croda International (LON:CRDAGet Free Report) last posted its quarterly earnings results on Tuesday, July 28th. The company reported GBX 72.20 EPS for the quarter. Croda International had a net margin of 4.61% and a return on equity of 3.65%. On average, equities research analysts expect that Croda International Plc will post 181.8307268 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on CRDA shares. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a GBX 3,300 target price on shares of Croda International in a research note on Wednesday, July 29th. Berenberg Bank reissued a “buy” rating and issued a GBX 3,600 price target on shares of Croda International in a report on Wednesday, July 29th. Jefferies Financial Group restated a “buy” rating and set a GBX 3,500 price target on shares of Croda International in a research note on Wednesday, July 29th. Finally, Citigroup lifted their target price on shares of Croda International from GBX 3,050 to GBX 3,200 and gave the stock a “neutral” rating in a research note on Wednesday, July 29th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 3,390.

Check Out Our Latest Stock Analysis on Croda International

About Croda International

(Get Free Report)

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.

Featured Articles

Insider Buying and Selling by Quarter for Croda International (LON:CRDA)

Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.